Source: Eur Respir J 2009; 34: 1072-1078
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Garcia-Vidal C., Almagro P., Romani V., Rodriguez-Carballeira M., Cuchi E., Canales L., Blasco D., Heredia J. L., Garau J.. Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study. Eur Respir J 2009; 34: 1072-1078

Member's Comments

No comment yet.

Related content which might interest you: Impact of Pseudomonas aeruginosa on exacerbation and death in patients with chronic obstructive pulmonary disease. Source: International Congress 2019 – Airway infection in COPD Year: 2019 Severe exacerbations of chronic obstructive pulmonary disease (COPD) due to Pseudomonas aeruginosa: resistance to common antibiotics Source: Eur Respir J 2001; 18: Suppl. 33, 540s Year: 2001 Pseudomonas aeruginosa drug susceptibility in patients hospitalized with COPD exacerbation and bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001 Pseudomonas aeruginosa and antibiotic resistance in acute exacerbations of COPD (AECOPD) Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa Year: 2009 COPD and pseudomonas aeruginosa, an association Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 A study of exacerbations by Gram-negative organisms in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007 The impact of pseudomonas aeruginosa in the sputum of patients presenting with acute COPD exacerbation Source: Annual Congress 2004 - Role of infection in COPD Year: 2004 Mycoplasma pneumoniae infection and acute exacerbations of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Prevalence and risk factors for Aspergillus spp. colonization in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD): The multi-center FUNGI-COPD study Source: Annual Congress 2010 - Various aspects of respiratory epidemiology Year: 2010 Robustness of assessment of pulmonary endpoints in phase 3 trials with ARD-3150 in non-cystic fibrosis bronchiectasis (NCFB) patients with chronic Pseudomonas aeruginosa (PA) infections Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015 Acute exacerbations of COPD due to pseudomonas aeruginosa: Impact of antimicrobial resistance Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 Community-acquired pneumonia (CAP): differences between patients with chronic obstructive pulmonary disease (COPD) and those without COPD Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study Source: Eur Respir J 2013; 41: 1107-1115 Year: 2013 The role of Moraxella catarrhalis in COPD Source: Annual Congress 2005 - COPD: role of infection Year: 2005 Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Bacterial infection in hospitalized patients of acute exacerbation of COPD and their relation to lung function: A prospective study Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016 Genomic variability of haemophilus in patients with COPD Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006 Infection as a comorbidity of COPD Source: Eur Respir J 2010; 35: 1209-1215 Year: 2010 Pseudomonas infection and home oxygen therapy can increase readmission in patients with acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2017 – Management of COPD Year: 2017